125 related articles for article (PubMed ID: 24861078)
1. Targeting angiogenic pathway for chemoprevention of experimental colon cancer using C-phycocyanin as cyclooxygenase-2 inhibitor.
Saini MK; Sanyal SN
Biochem Cell Biol; 2014 Jun; 92(3):206-18. PubMed ID: 24861078
[TBL] [Abstract][Full Text] [Related]
2. Piroxicam and C-phycocyanin mediated apoptosis in 1,2-dimethylhydrazine dihydrochloride induced colon carcinogenesis: exploring the mitochondrial pathway.
Saini MK; Sanyal SN; Vaiphei K
Nutr Cancer; 2012 Apr; 64(3):409-18. PubMed ID: 22369161
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle regulation and apoptotic cell death in experimental colon carcinogenesis: intervening with cyclooxygenase-2 inhibitors.
Saini MK; Sanyal SN
Nutr Cancer; 2015; 67(4):620-36. PubMed ID: 25825916
[TBL] [Abstract][Full Text] [Related]
4. Diclofenac, a selective COX-2 inhibitor, inhibits DMH-induced colon tumorigenesis through suppression of MCP-1, MIP-1α and VEGF.
Kaur J; Sanyal SN
Mol Carcinog; 2011 Sep; 50(9):707-18. PubMed ID: 21268133
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of Colon Cancer through Inhibition of Angiogenesis and Induction of Apoptosis by Nonsteroidal Anti-Inflammatory Drugs.
Ghanghas P; Jain S; Rana C; Sanyal SN
J Environ Pathol Toxicol Oncol; 2016; 35(3):273-289. PubMed ID: 27910782
[TBL] [Abstract][Full Text] [Related]
6. PTEN regulates apoptotic cell death through PI3-K/Akt/GSK3β signaling pathway in DMH induced early colon carcinogenesis in rat.
Saini MK; Sanyal SN
Exp Mol Pathol; 2012 Aug; 93(1):135-46. PubMed ID: 22561258
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of DMH-induced rat colon carcinoma initiation by combination administration of piroxicam and C-phycocyanin.
Saini MK; Vaiphei K; Sanyal SN
Mol Cell Biochem; 2012 Feb; 361(1-2):217-28. PubMed ID: 21989718
[TBL] [Abstract][Full Text] [Related]
8. Role of cytokines and Jak3/Stat3 signaling in the 1,2-dimethylhydrazine dihydrochloride-induced rat model of colon carcinogenesis: early target in the anticancer strategy.
Saini MK; Vaish V; Sanyal SN
Eur J Cancer Prev; 2013 May; 22(3):215-28. PubMed ID: 23514809
[TBL] [Abstract][Full Text] [Related]
9. Piroxicam and c-phycocyanin prevent colon carcinogenesis by inhibition of membrane fluidity and canonical Wnt/β-catenin signaling while up-regulating ligand dependent transcription factor PPARγ.
Saini MK; Sanyal SN
Biomed Pharmacother; 2014 Jun; 68(5):537-50. PubMed ID: 24721324
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
11. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
[TBL] [Abstract][Full Text] [Related]
12. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
13. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma.
Tanaka S; Tatsuguchi A; Futagami S; Gudis K; Wada K; Seo T; Mitsui K; Yonezawa M; Nagata K; Fujimori S; Tsukui T; Kishida T; Sakamoto C
Gut; 2006 Jan; 55(1):54-61. PubMed ID: 16085694
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
[TBL] [Abstract][Full Text] [Related]
17. Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice.
Nasr M; Selima E; Hamed O; Kazem A
Eur J Pharmacol; 2014 Jan; 723():267-75. PubMed ID: 24291100
[TBL] [Abstract][Full Text] [Related]
18. Angiostatic role of the selective cyclooxygenase-2 inhibitor etoricoxib (MK0663) in experimental lung cancer.
Nadda N; Vaish V; Setia S; Sanyal SN
Biomed Pharmacother; 2012 Sep; 66(6):474-83. PubMed ID: 22681911
[TBL] [Abstract][Full Text] [Related]
19. Dolastatin 15, a mollusk linear peptide, and Celecoxib, a selective cyclooxygenase-2 inhibitor, prevent preneoplastic colonic lesions and induce apoptosis through inhibition of the regulatory transcription factor NF-κB and an inflammatory protein, iNOS.
Piplani H; Vaish V; Sanyal SN
Eur J Cancer Prev; 2012 Nov; 21(6):511-22. PubMed ID: 22441428
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
